[Comparative parameters of myelotoxicity in patients treated with simultaneous chemotherapy and radiotherapy or only radiotherapy]
- PMID: 15017898
[Comparative parameters of myelotoxicity in patients treated with simultaneous chemotherapy and radiotherapy or only radiotherapy]
Abstract
Background: The Modern oncological treatment usually consists of the different kind of the therapies. Improvement of survival and local control of disease could be possible with combined treatments: surgery, radiotherapy, chemotherapy, etc. However if these treatments are given concomitantly one can expect higher toxicity.
Aim: Comparation of parameters of miclotoxicity: red blood cell count, white blood cell count, platelets and hemoglobin in patients with advanced cervical carcinoma treated with concomitant chemo-radiotherapy versus radiotherapy alone.
Patients and methods: From 1997-1999, we performed prospective, by randomised, study, and 80 patients were divided in two groups: Group A--40 patients treated with concomitant chemo-radiotherapy versus, Group B--40 patients treated with radiotherapy alone. Red blood cell count, white blood cell count, platelets and hemoglobin were evaluated before enrollement, during the theraphy, after 3 and 6 months, according to CTC toxicity criteria.
Results: We perform statistical analysis using H2 test, and we found no significant difference in mild nad severe toxicity in red blood cell count, white blood cell count, platelets and hemoglobin among groups.
Similar articles
-
[Comparison of gastrointestinal toxicity in patients with advanced cervical carcinoma treated with concomitant chemotherapy and radiotherapy versus radiotherapy alone].Med Arh. 2004;58(4):214-7. Med Arh. 2004. PMID: 15526587 Clinical Trial. Bosnian.
-
[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].Ai Zheng. 2008 Sep;27(9):942-6. Ai Zheng. 2008. PMID: 18799032 Clinical Trial. Chinese.
-
[Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):763-7. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24406134 Chinese.
-
[Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].Bull Cancer. 1990;77(10):1007-24. Bull Cancer. 1990. PMID: 2249011 Review. French.
-
Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.Gynecol Oncol. 1994 Sep;54(3):307-15. doi: 10.1006/gyno.1994.1215. Gynecol Oncol. 1994. PMID: 7522200 Review.
Cited by
-
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD008285. doi: 10.1002/14651858.CD008285. Cochrane Database Syst Rev. 2010. PMID: 20091664 Free PMC article.
-
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010401. doi: 10.1002/14651858.CD010401.pub2. Cochrane Database Syst Rev. 2014. PMID: 25470408 Free PMC article.
-
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.Am Soc Clin Oncol Educ Book. 2015:e299-309. doi: 10.14694/EdBook_AM.2015.35.e299. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993189 Free PMC article.
-
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study.Tumour Biol. 2014 Mar;35(3):2741-6. doi: 10.1007/s13277-013-1361-3. Tumour Biol. 2014. PMID: 24234333 Clinical Trial.
-
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD002225. doi: 10.1002/14651858.CD002225.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034873 Free PMC article.